SCHEMBL14976394

SCHEMBL14976394

CCCCOC(=O)NC(C)C(O)C1CCCCC1

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.46
TSHR P16473 1/20 0.40
EPHX1 P07099 2/20 0.40
EPHX2 P34913 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CTSK P43235 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8325170 0.84 HRH3 (0.44) HRH3TSHREPHX1EPHX2SMN1; SMN2
SCHEMBL13506436 0.82 HRH3 (0.46) HRH3TSHREPHX1EPHX2SMN1; SMN2
SCHEMBL13387471 0.82 HRH3 (0.46) HRH3TSHREPHX1EPHX2SMN1; SMN2
SCHEMBL8303908 0.80 HRH3 (0.43) HRH3TSHREPHX1EPHX2SMN1; SMN2
SCHEMBL7451255 0.80 HRH3 (0.43) HRH3TSHREPHX1EPHX2SMN1; SMN2
SCHEMBL4683301 0.79 HRH3 (0.42) HRH3TSHREPHX1EPHX2SMN1; SMN2
SCHEMBL23160898 0.77 HRH3 (0.40) HRH3TSHREPHX1EPHX2SMN1; SMN2
SCHEMBL38661176 0.77 EPHX1 (0.47) EPHX1SMN1; SMN2MAPK1NPC1HPGD
SCHEMBL3655319 0.77 HRH3 (0.41) HRH3TSHREPHX1EPHX2SMN1; SMN2
SCHEMBL9822641 0.76 HRH3 (0.39) HRH3TSHREPHX1EPHX2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2782903-A1 NOVEL PYRROLIDINE DERIVATIVES AS INHIBITORS OF CATHEPSIN F.HOFFMANN-LA ROCHE AG (CH) 2014-10-01 EP disclosed
WO-2013076063-A1 NOVEL PYRROLIDINE DERIVATIVES AS INHIBITORS OF CATHEPSIN F. HOFFMANN-LA ROCHE AG (CH) 2013-05-30 WO disclosed